Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1935 1
1945 1
1946 3
1947 3
1948 7
1949 1
1950 4
1952 12
1953 1
1954 5
1955 3
1956 8
1957 11
1958 6
1959 13
1960 9
1961 13
1962 9
1963 16
1964 18
1965 13
1966 14
1967 15
1968 14
1969 6
1970 11
1971 7
1972 17
1973 6
1974 7
1975 15
1976 16
1977 18
1978 12
1979 10
1980 16
1981 17
1982 13
1983 19
1984 17
1985 23
1986 16
1987 22
1988 16
1989 27
1990 26
1991 22
1992 11
1993 28
1994 13
1995 21
1996 13
1997 32
1998 25
1999 23
2000 24
2001 29
2002 29
2003 25
2004 33
2005 15
2006 26
2007 34
2008 44
2009 49
2010 62
2011 72
2012 63
2013 74
2014 50
2015 62
2016 69
2017 63
2018 74
2019 69
2020 78
2021 81
2022 75
2023 58
2024 27

Text availability

Article attribute

Article type

Publication date

Search Results

1,863 results

Results by year

Filters applied: . Clear all
Page 1
Effect of NFX-179 MEK inhibitor on cutaneous neurofibromas in persons with neurofibromatosis type 1.
Sarin KY, Bradshaw M, O'Mara C, Shahryari J, Kincaid J, Kempers S, Tu JH, Dhawan S, DuBois J, Wilson D, Horwath P, de Souza MP, Powala C, Kochendoerfer GG, Plotkin SR, Webster GF, Le LQ. Sarin KY, et al. Among authors: dubois j. Sci Adv. 2024 May 3;10(18):eadk4946. doi: 10.1126/sciadv.adk4946. Epub 2024 May 1. Sci Adv. 2024. PMID: 38691597 Free PMC article. Clinical Trial.
Reassessing the Chronic Lymphocytic Leukemia International Prognostic Index in the era of targeted therapies.
Langerbeins P, Giza A, Robrecht S, Cramer P, von Tresckow J, Al-Sawaf O, Fink AM, Fürstenau M, Kutsch N, Simon F, Goede V, Hoechstetter MA, Niemann CU, da Cunha-Bang C, Kater AP, Dubois J, Gregor M, Staber PB, Tausch E, Schneider C, Stilgenbauer S, Eichhorst B, Fischer K, Hallek MJ. Langerbeins P, et al. Among authors: dubois j. Blood. 2024 Apr 15:blood.2023022564. doi: 10.1182/blood.2023022564. Online ahead of print. Blood. 2024. PMID: 38620092
[Autoimmune bullous diseases in children].
Bruschi L, Minisini F, Nidegger A, Dubois J, Iselin C, Chang YT, Guenova E, Morren MA. Bruschi L, et al. Among authors: dubois j. Rev Med Suisse. 2024 Mar 27;20(867):638-647. doi: 10.53738/REVMED.2024.20.867.638. Rev Med Suisse. 2024. PMID: 38563538 Review. French.
[Contribution of connected prescriptions (NetSIG) for the management of molecular pathology exams].
Martin L, Chapusot C, Tarris G, Remond A, Millière A, Pioche C, Dubois J, Laffage N, Aubry M, Dubois LM, Andrianiaina H, Provost N, Funes de la Vega M, Grangier N, Harizay F, Douchet C, Tournier B, Guibert C, Aubriot-Lorton MH. Martin L, et al. Among authors: dubois j. Ann Pathol. 2024 Mar 18:S0242-6498(24)00050-6. doi: 10.1016/j.annpat.2024.02.009. Online ahead of print. Ann Pathol. 2024. PMID: 38503611 Free article. French.
1,863 results